Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fleischer

Showing results (131-140 of 257) with videos related to

Pageof 26
Sort By:
The Journal of Allergy and Clinical Immunology|April 7, 2012
Successful treatment of eosinophilic esophagitis with ciclesonideShauna Schroeder, David M Fleischer, Joanne C Masterson, et al.
Pediatric Clinics of North America|October 13, 2015
Current Options for the Treatment of Food AllergyBruce J Lanser, Benjamin L Wright, Kelly A Orgel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 12, 2017
The allergenicity of genetically modified foods from genetically engineered crops: A narrative and systematic reviewS Eliza Dunn, John L Vicini, Kevin C Glenn, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 18, 2019
Comparison of practice patterns among Canadian allergists before and after NIAID guideline recommendationsElissa M Abrams, Lianne Soller, Alexander G Singer, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2018
Additional oral food challenge considerationsJ Andrew Bird, David M Fleischer, Marion Groetch, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2020
Improvements in eliciting dose across baseline sensitivities following 12 months of epicutaneous immunotherapy (EPIT) in peanut-allergic children aged 4 to 11 yearsMatthew Greenhawt, Edwin H Kim, Dianne E Campbell, et al.
Expert Review of Clinical Immunology|February 7, 2024
Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergyChristophe Dupont, A Wesley Burks, David M Fleischer, et al.
Nanotechnology|April 15, 2010
Pulsed gate sweep strategies for hysteresis reduction in carbon nanotube transistors for low concentration NO(2) gas detectionM Mattmann, C Roman, T Helbling, et al.
Allergy|November 30, 2016
LEAPing through the looking glass: secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introductionM Greenhawt, D M Fleischer, E S Chan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2024
Upper respiratory tract infections have minimal impact on neffy's pharmacokinetics or pharmacodynamicsJohn Oppenheimer, Thomas B Casale, Carlos A Camargo, et al.
Pageof 26

Showing results (131-140 of 257) with videos related to

Sort By:
Pageof 26
The Journal of Allergy and Clinical Immunology|April 7, 2012
Successful treatment of eosinophilic esophagitis with ciclesonideShauna Schroeder, David M Fleischer, Joanne C Masterson, et al.
Pediatric Clinics of North America|October 13, 2015
Current Options for the Treatment of Food AllergyBruce J Lanser, Benjamin L Wright, Kelly A Orgel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 12, 2017
The allergenicity of genetically modified foods from genetically engineered crops: A narrative and systematic reviewS Eliza Dunn, John L Vicini, Kevin C Glenn, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 18, 2019
Comparison of practice patterns among Canadian allergists before and after NIAID guideline recommendationsElissa M Abrams, Lianne Soller, Alexander G Singer, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2018
Additional oral food challenge considerationsJ Andrew Bird, David M Fleischer, Marion Groetch, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2020
Improvements in eliciting dose across baseline sensitivities following 12 months of epicutaneous immunotherapy (EPIT) in peanut-allergic children aged 4 to 11 yearsMatthew Greenhawt, Edwin H Kim, Dianne E Campbell, et al.
Expert Review of Clinical Immunology|February 7, 2024
Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergyChristophe Dupont, A Wesley Burks, David M Fleischer, et al.
Nanotechnology|April 15, 2010
Pulsed gate sweep strategies for hysteresis reduction in carbon nanotube transistors for low concentration NO(2) gas detectionM Mattmann, C Roman, T Helbling, et al.
Allergy|November 30, 2016
LEAPing through the looking glass: secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introductionM Greenhawt, D M Fleischer, E S Chan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2024
Upper respiratory tract infections have minimal impact on neffy's pharmacokinetics or pharmacodynamicsJohn Oppenheimer, Thomas B Casale, Carlos A Camargo, et al.
Pageof 26